𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of 39 Crohn's disease risk loci in Swedish inflammatory bowel disease patients

✍ Scribed by Leif Törkvist; Jonas Halfvarson; Rick T.H. Ong; Mikael Lördal; Urban Sjöqvist; Francesca Bresso; Jan Björk; Ragnar Befrits; Robert Löfberg; Johannes Blom; Marie Carlson; Leonid Padyukov; Mauro D'Amato; Mark Seielstad; Sven Pettersson

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
60 KB
Volume
16
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of flagellin in Crohn's disease: Em
Role of flagellin in Crohn's disease: Emblematic of the progress and enigmas in understanding inflammatory bowel disease
✍ Matam Vijay-Kumar; Andrew T. Gewirtz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

Elevated immune responses to the enteric microbiota have long been associated with inflammatory bowel disease (IBD), especially Crohn's disease. In recent years there has been considerable progress in identifying a number of the specific bacterial and host molecules whose interactions mediate these

Lost in translation: Helping patients un
Lost in translation: Helping patients understand the risks of inflammatory bowel disease therapy
✍ Corey A. Siegel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Patients with inflammatory bowel disease are commonly treated with immunomodulators and biologic therapy. These treatments can be very effective, but are associated with risks of adverse events that need to be discussed with patients. Effectively communicating risks of therapy can be challenging bas

Nonadherence in inflammatory bowel disea
Nonadherence in inflammatory bowel disease: Results of factor analysis
✍ Petr Červený; Martin Bortlík; Aleš Kuběna; Jiří Vlček; Peter Laszlo Lakatos; Mil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 1 views

## Background: The purpose of the study was to assess overall nonadherence to treatment among patients with crohn's disease (cd) and ulcerative colitis (uc) in a single tertiary center. ## Methods: A total of 177 patients were enrolled in this study (84 males, 93 females; 117 cd, 60 uc). patients

Risk of malignant lymphoma in patients w
Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study
✍ A.C.W. Vos; N. Bakkal; R.C. Minnee; M.K. Casparie; D.J. de Jong; G. Dijkstra; P. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB 👁 2 views

Background: Immune suppressant medications such as thiopurines and anti-tumor necrosis factor agents are important for maintaining disease control in most patients with inflammatory bowel diseases (IBDs); however, their use has been associated with the development of malignant lymphoma. The purpose